GB9924352D0 - Methods,compositions and applications relating to the generation of novel plant viral particles - Google Patents

Methods,compositions and applications relating to the generation of novel plant viral particles

Info

Publication number
GB9924352D0
GB9924352D0 GBGB9924352.9A GB9924352A GB9924352D0 GB 9924352 D0 GB9924352 D0 GB 9924352D0 GB 9924352 A GB9924352 A GB 9924352A GB 9924352 D0 GB9924352 D0 GB 9924352D0
Authority
GB
United Kingdom
Prior art keywords
compositions
generation
methods
viral particles
plant viral
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB9924352.9A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
JONES TIM D
Original Assignee
JONES TIM D
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by JONES TIM D filed Critical JONES TIM D
Priority to GBGB9924352.9A priority Critical patent/GB9924352D0/en
Publication of GB9924352D0 publication Critical patent/GB9924352D0/en
Priority to CNA008167532A priority patent/CN1471580A/zh
Priority to BR0014861-0A priority patent/BR0014861A/pt
Priority to CA002387626A priority patent/CA2387626A1/fr
Priority to KR1020027004778A priority patent/KR100880477B1/ko
Priority to EP00972153A priority patent/EP1235910A1/fr
Priority to US10/110,511 priority patent/US7135282B1/en
Priority to IL14907700A priority patent/IL149077A0/xx
Priority to MXPA02003789A priority patent/MXPA02003789A/es
Priority to JP2001530485A priority patent/JP2003534771A/ja
Priority to PL00354933A priority patent/PL354933A1/xx
Priority to CZ20021303A priority patent/CZ20021303A3/cs
Priority to CNA2009101426265A priority patent/CN101591647A/zh
Priority to AU10852/01A priority patent/AU785020B2/en
Priority to PCT/US2000/028430 priority patent/WO2001027282A1/fr
Priority to CO00078905A priority patent/CO5280142A1/es
Priority to ARP000105455A priority patent/AR026066A1/es
Priority to ZA200202815A priority patent/ZA200202815B/xx
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8201—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation
    • C12N15/8202—Methods for introducing genetic material into plant cells, e.g. DNA, RNA, stable or transient incorporation, tissue culture methods adapted for transformation by biological means, e.g. cell mediated or natural vector
    • C12N15/8203—Virus mediated transformation
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/82—Vectors or expression systems specially adapted for eukaryotic hosts for plant cells, e.g. plant artificial chromosomes (PACs)
    • C12N15/8241—Phenotypically and genetically modified plants via recombinant DNA technology
    • C12N15/8242—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits
    • C12N15/8257—Phenotypically and genetically modified plants via recombinant DNA technology with non-agronomic quality (output) traits, e.g. for industrial processing; Value added, non-agronomic traits for the production of primary gene products, e.g. pharmaceutical products, interferon
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18711—Rubulavirus, e.g. mumps virus, parainfluenza 2,4
    • C12N2760/18722—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/20011—Rhabdoviridae
    • C12N2760/20111—Lyssavirus, e.g. rabies virus
    • C12N2760/20122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • General Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Virology (AREA)
  • Plant Pathology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Cell Biology (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Veterinary Medicine (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
GBGB9924352.9A 1999-10-14 1999-10-14 Methods,compositions and applications relating to the generation of novel plant viral particles Ceased GB9924352D0 (en)

Priority Applications (18)

Application Number Priority Date Filing Date Title
GBGB9924352.9A GB9924352D0 (en) 1999-10-14 1999-10-14 Methods,compositions and applications relating to the generation of novel plant viral particles
PCT/US2000/028430 WO2001027282A1 (fr) 1999-10-14 2000-10-13 Particules virales comportant des epitopes internes exogenes
MXPA02003789A MXPA02003789A (es) 1999-10-14 2000-10-13 Particulas virales con epitopes internos exogenos.
PL00354933A PL354933A1 (en) 1999-10-14 2000-10-13 Plant virus particles with exogenous internal eitopes
CA002387626A CA2387626A1 (fr) 1999-10-14 2000-10-13 Particules virales comportant des epitopes internes exogenes
KR1020027004778A KR100880477B1 (ko) 1999-10-14 2000-10-13 외인성 내부 에피토프를 갖는 바이러스 입자
EP00972153A EP1235910A1 (fr) 1999-10-14 2000-10-13 Particules virales comportant des epitopes internes exogenes
US10/110,511 US7135282B1 (en) 1999-10-14 2000-10-13 Viral particles with exogenous internal epitopes
IL14907700A IL149077A0 (en) 1999-10-14 2000-10-13 Viral particles with exogenous internal epitopes
CNA008167532A CN1471580A (zh) 1999-10-14 2000-10-13 含有外源性内表位的病毒颗粒
JP2001530485A JP2003534771A (ja) 1999-10-14 2000-10-13 外来性内部エピトープをもつウィルス粒子
BR0014861-0A BR0014861A (pt) 1999-10-14 2000-10-13 Partìculas virais com epìtopos internos exógenos
CZ20021303A CZ20021303A3 (cs) 1999-10-14 2000-10-13 Virové částice s exogenními epitopy uvnitř částice
CNA2009101426265A CN101591647A (zh) 1999-10-14 2000-10-13 含有外源性内表位的病毒颗粒
AU10852/01A AU785020B2 (en) 1999-10-14 2000-10-13 Plant Virus particles with exogenous internal eitopes
ARP000105455A AR026066A1 (es) 1999-10-14 2000-10-17 Particulas virales con epitopos internos exogenos.
CO00078905A CO5280142A1 (es) 1999-10-14 2000-10-17 Particulas virales con epitopos exogenos . .
ZA200202815A ZA200202815B (en) 1999-10-14 2002-04-10 Viral particles with exogenous internal epitopes.

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9924352.9A GB9924352D0 (en) 1999-10-14 1999-10-14 Methods,compositions and applications relating to the generation of novel plant viral particles

Publications (1)

Publication Number Publication Date
GB9924352D0 true GB9924352D0 (en) 1999-12-15

Family

ID=10862753

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9924352.9A Ceased GB9924352D0 (en) 1999-10-14 1999-10-14 Methods,compositions and applications relating to the generation of novel plant viral particles

Country Status (16)

Country Link
EP (1) EP1235910A1 (fr)
JP (1) JP2003534771A (fr)
KR (1) KR100880477B1 (fr)
CN (2) CN1471580A (fr)
AR (1) AR026066A1 (fr)
AU (1) AU785020B2 (fr)
BR (1) BR0014861A (fr)
CA (1) CA2387626A1 (fr)
CO (1) CO5280142A1 (fr)
CZ (1) CZ20021303A3 (fr)
GB (1) GB9924352D0 (fr)
IL (1) IL149077A0 (fr)
MX (1) MXPA02003789A (fr)
PL (1) PL354933A1 (fr)
WO (1) WO2001027282A1 (fr)
ZA (1) ZA200202815B (fr)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003000855A2 (fr) * 2001-06-21 2003-01-03 Uab Research Foundation Proteines de capsides chimeriques et leurs utilisations
US8101189B2 (en) 2002-07-05 2012-01-24 Folia Biotech Inc. Vaccines and immunopotentiating compositions and methods for making and using them
MXPA05000287A (es) 2002-07-05 2005-09-08 Leclerc Denis Particula viral adyuvante.
GB2434367B (en) 2004-10-05 2010-05-12 Diversa Corp Improved vaccines
CA2608515A1 (fr) * 2005-06-01 2007-05-10 Dow Global Technolgies Inc. Production de particules multivalentes semblables a des virus
BRPI0613625A2 (pt) * 2005-07-19 2011-01-18 Dow Global Technologies Inc vacinas da gripe recombinantes
CN101784655A (zh) * 2007-04-27 2010-07-21 菲尼克斯股份有限公司 可溶性重组二十面体病毒样颗粒的改良生成和体内装配
WO2013003353A2 (fr) * 2011-06-30 2013-01-03 Stc.Unm Plasmides et procédés pour la présentation de peptide et sélection par affinité sur des particules de type virus de bactériophages à arn

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9108386D0 (en) * 1991-04-19 1991-06-05 Agricultural Genetics Co Modified plant viruses as vectors
GB9712282D0 (en) * 1997-06-12 1997-08-13 Innes John Centre Innov Ltd Epitope presentation system

Also Published As

Publication number Publication date
JP2003534771A (ja) 2003-11-25
PL354933A1 (en) 2004-03-22
AR026066A1 (es) 2002-12-26
CO5280142A1 (es) 2003-05-30
CN1471580A (zh) 2004-01-28
EP1235910A1 (fr) 2002-09-04
BR0014861A (pt) 2002-07-16
WO2001027282A1 (fr) 2001-04-19
WO2001027282A8 (fr) 2001-08-16
KR20020040868A (ko) 2002-05-30
CN101591647A (zh) 2009-12-02
AU785020B2 (en) 2006-08-24
ZA200202815B (en) 2003-08-27
MXPA02003789A (es) 2002-09-30
IL149077A0 (en) 2002-11-10
AU1085201A (en) 2001-04-23
CA2387626A1 (fr) 2001-04-19
CZ20021303A3 (cs) 2002-10-16
KR100880477B1 (ko) 2009-01-28

Similar Documents

Publication Publication Date Title
IL133883A0 (en) Directed cytolysis of target cells, agents and compositions causing cytolysis, and compounds that can be used to produce the agents
MXPA01007710A (es) Agente de secado por congelacion que contiene paramilon, su produccion y uso.
MXPA03008714A (es) Polimeros secuenciados y composiciones cosmeticas que comprenden tales polimeros.
AU9284101A (en) Inorganic matrix compositions, composites and process of making the same
HUP0400927A3 (en) New crystalline form and pure modafinil, process of preparing them, and pharmaceutical compositions containing the new crystalline form
IL158885A0 (en) Plant artificial chromosomes, uses thereof and methods of preparing plant artificial chromosomes
WO2000005381A3 (fr) Expression d'enzymes impliquees dans une modification de la cellulose
HK1085495A1 (en) Spherical powder components and solid cosmetic compositions comprising thereof
PL360254A1 (en) Pharmaceutical compositions
ZA200202816B (en) Modified plant viruses and methods of use thereof.
AU3885301A (en) Anti-mycobacterium compositions and methods of preparing and using same
AP2001002300A0 (en) Hiv immunogenic compositions and methods
AU6838501A (en) Enzyme-catalyzed polyamides and compositions and processes of preparing and using the same
IL145520A0 (en) Flame-retarding composition and process for the preparation thereof
GB9924352D0 (en) Methods,compositions and applications relating to the generation of novel plant viral particles
CA2327784A1 (fr) Triazolones a effet neuroprotecteur
EP1113815A4 (fr) Compositions immunogenes et leurs utilisations
AU2002362761A1 (en) Generation of virus-like particles by vsv
EP1421850A4 (fr) Compositions activant la resistance des plantes aux maladies et procede permettant de fabriquer ces compositions
MY120550A (en) Substituted 1,2,3,4,5,6-hexahydro-2,6-methano-3-benzazocin-10-ols, processes for preparing them and their use as pharmaceutical compositions.
AU2001246339A1 (en) Lyophilized powder of lentinan and the process of preparation thereof
AU2001251583A1 (en) Method for improving bonding of rigid, thermosetting compositions to hydrophilicsurfaces, and the articles formed thereby
GB0210152D0 (en) Use of plant materials
HUP0101393A3 (en) Transfecting compositions sensitive to reducing conditions, pharmaceutical compositions containing them, and their applications
EP1218393A4 (fr) Compositions de ciblage de cellules et procedes d'utilisation de celles-ci

Legal Events

Date Code Title Description
COOA Change in applicant's name or ownership of the application
AT Applications terminated before publication under section 16(1)